reserpine has been researched along with Somatoform Disorders in 1 studies
Reserpine: An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria. Reserpine inhibits the uptake of norepinephrine into storage vesicles resulting in depletion of catecholamines and serotonin from central and peripheral axon terminals. It has been used as an antihypertensive and an antipsychotic as well as a research tool, but its adverse effects limit its clinical use.
reserpine : An alkaloid found in the roots of Rauwolfia serpentina and R. vomitoria.
Somatoform Disorders: Disorders having the presence of physical symptoms that suggest a general medical condition but that are not fully explained by another medical condition, by the direct effects of a substance, or by another mental disorder. The MEDICALLY UNEXPLAINED SYMPTOMS must cause clinically significant distress or impairment in social, occupational, or other areas of functioning. In contrast to FACTITIOUS DISORDERS and MALINGERING, the physical symptoms are not under voluntary control. (APA, DSM-V)
| Excerpt | Relevance | Reference |
|---|---|---|
| "The reserpine-treated animal may be useful for the research of not only fibromyalgia syndrome but also FSS, especially for the research focusing on the hypothesis that FSS is associated with the disturbance of endogenous monoamine system." | 1.48 | Monoamine system disruption induces functional somatic syndromes associated symptomatology in mice. ( Azuma, R; Kawasaki, S; Miwa, M; Murai, S; Nagakura, Y; Ohsaka, N; Saito, H; Takahashi, S; Takebayashi, Y, 2018) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nagakura, Y | 1 |
| Ohsaka, N | 1 |
| Azuma, R | 1 |
| Takahashi, S | 1 |
| Takebayashi, Y | 1 |
| Kawasaki, S | 1 |
| Murai, S | 1 |
| Miwa, M | 1 |
| Saito, H | 1 |
1 other study available for reserpine and Somatoform Disorders
| Article | Year |
|---|---|
Monoamine system disruption induces functional somatic syndromes associated symptomatology in mice.
Topics: Animals; Biogenic Monoamines; Blepharoptosis; Body Temperature; Body Weight; Central Nervous System; | 2018 |